Tag: Beta 3 adrenergic agonist

Affecting an estimated 20% of the global population, overactive bladder (OAB) significantly impacts quality of life [1.7.4]. For those seeking treatment, a key question arises: **is Mirabegron an anticholinergic?** The answer is no; it represents a different class of medication entirely [1.2.2, 1.2.3].

According to the National Institutes of Health, overactive bladder (OAB) affects a significant portion of the adult population, causing disruptive symptoms like urgency and frequent urination. For many patients, the medication **Mirabegron** offers an effective treatment option, particularly for those who have found traditional therapies unsuitable or ineffective. It is also used to treat neurogenic detrusor overactivity in certain pediatric populations.

According to MedlinePlus, the active ingredient mirabegron, often marketed under the brand name Myrbetriq, is used to treat overactive bladder. While the term 'Mirabel Tablet' may lead to confusion with a taste-enhancing product, in a medical context, it is most likely a reference to Myrbetriq, the medication used to treat symptoms such as urinary urgency, frequency, and leakage. This article clarifies the actual use of mirabegron and distinguishes it from the similarly named, non-medical alternative.

Overactive bladder (OAB) affects millions of people, causing disruptive symptoms like sudden, frequent urges to urinate. **Miraquick 25** is a prescription medication containing mirabegron, a beta-3 adrenergic agonist used to manage these conditions by helping to relax the bladder muscle.